The strategic plan of Tufts Medical Center identified Cancer as a primary target. Responding to this plan, the Board of Tufts Medical Center established the Molecular Oncology Research Institute (MORI). Philip N. Tsichlis MD, was appointed as its Executive Director on September 1, 2002.
MORI, a core component of the Tufts
Medical Center Cancer Center, has 17 faculty members currently and occupies a space of more than 31,000 square feet in the 75 Kneeland Street research building. Its mission is to explore the molecular mechanisms of neoplastic transformation and to promote the translation of basic research findings into the clinic. To achieve this goal, MORI scientists carry out research that spans the spectrum from gene discovery to target validation for drug development.
|
|
Upcoming Seminars
Inhibition
of PAX3 by TGF-b
Modulates Melanocyte Viability
Rutao
Cui, MD, PhD
Oncology Institute
Cardinal
Bernardin
Cancer
Center
Department of Pathology
Stritch School
of
Medicine
Loyola
University,
Chicago
Wednesday, June 17th,
12:30
Jaharis Bdg., Room 508
Host: Philip Tsichlis, M.D.
617 636-6184
[ Click Here for Additional Information ]
|
